info@ehidc.org

 202-624-3270

Social Determinants of Health

Digital Health Equity Summit

In November, eHI will be hosting a Digital Health Equity Summit. Attendees will learn how digital health tools are already being used to bridge geographical issues, language barriers, and affordability gaps, and how robust individual-level data can help health organizations improve patient outcomes. Panels will also explore how institutional practices and policies should change to ensure the inequities in our current health care system are not carried over as it continues to modernize.

WEBINAR: Sourcing and Utilizing SDOH Data for Whole-Person Care

March 25, 2021

What do social determinants of health (SDOH), health equity, and interoperability have in common? More than “buzzword bingo,” they are all critical building blocks to achieve the goal of whole-person care. Join LexisNexis Risk Solutions, eHI, and state healthcare leaders to discuss the critical role of data-driven approaches in designing, implementing, and evaluating state healthcare programs. 

Key points of discussion include:

  • How different states source and utilize SDOH data
  • Opportunities for data sharing and public-private collaboration to address vulnerable populations
  • Data-driven approaches to monitor health equity for COVID-19 vaccinations and beyond

 

Speakers: 

 


Dr. Chris Chen
Medical Medicaid Director
Washington State Health Care Authority

Dr. Christopher Chen, MD, MBA, is a Medical Director for Medicaid at the WA State Health Care Authority.  Dr. Chen is dedicated to serving the underserved and believes in the HCA’s mission to use innovative polices and purchasing strategies to address health disparities and perverse incentives. He helps guide clinical policy and strategy, and supports initiatives in health information technology, telehealth, quality, and health equity.

He previously served as the medical director of value management and associate medical director of hospital medicine at UW Medicine Valley Medical Center (VMC). In his prior work, Dr. Chen helped VMC navigate healthcare's shift from volume to value by leading participation in alternative payment models, strengthening post-acute relationships in partnership with the UW Post-Acute Care Network, developing care pathways to spread evidence based care, and connecting with community partners. 

He obtained his medical degree from the University of Pennsylvania School of Medicine and his business degree from The Wharton School. Dr. Chen completed his residency in internal medicine – primary care at the University of Washington and continues to practice as a hospitalist.


Stephanie Bennett, MPH
State Health IT Coordinator, Office of eHealth Innovation
State of Colorado

As the State Health IT Coordinator for the Office of eHealth Innovation in Colorado, Stephanie leads the coordination of state health technology efforts, as well as facilitates opportunities for collaboration within and between state agencies and external partners. Prior to her current role, Stephanie served as an Operations Advisor for the Governor's Office, where she led the training and implementation efforts for the state in Agile methodology. Previously, Stephanie was a Public Health Investigator for the City and County of Denver, where she led inspections and compliance for food safety at temporary events. She holds a Master of Public Health from Colorado State University and a Bachelor of Science in English from Hanover College.

Gary Sing
Director of Delivery System Investment and Social Services Integration
MassHealth

Gary Sing is the Director of Delivery System Investment and Social Services Integration at MassHealth, Massachusetts’ Medicaid agency. He is a member of the Innovation Team at MassHealth and oversees various investment programs, including MassHealth’s Delivery System Reform Incentive Payment (DSRIP) Program. Gary also works to advance integration of health-related social services into MassHealth, which includes overseeing the design and implementation of the Flexible Services program. This pilot program allows MassHealth Accountable Care Organizations to use state/federal Medicaid dollars to pay for certain health-related nutrition and housing supports for certain eligible members.

Prior to joining MassHealth, Gary worked as a strategy consultant in the life sciences industry, earned a PhD from Harvard University in Engineering Sciences with a focus on computational neuroscience, and earned dual B.S.E.’s from Duke University in Biomedical Engineering and Electrical Engineering.

Diana Zuskov
Director, Market Planning/Strategy, Government Healthcare & Public Health
Lexis Nexis Risk Solutions

Diana Zuskov leads Market Planning for Government Healthcare at LexisNexis Risk Solutions where she’s responsible for healthcare and public health strategy across Federal, State, and Local government agencies. Diana is passionate about innovations at the intersection of Medicaid and public health and brings expertise in population health, health communication, health services research, and digital health and innovation. Prior to joining LexisNexis, she led Market Solutions for Medicaid & Public Sector markets at a health engagement company and built a portfolio of evidence-based, text messaging programs for underserved populations distributed by health plans, state agencies, and providers. Diana holds a Master’s in Public Health in Health Behavior from University of North Carolina at Chapel Hill and lives in Washington, DC with her French Bulldog Lola.

 


Jen Covich Bordenick
Chief Executive Officer
eHI

For over 20 years, Jennifer has focused on quality and innovative technology solutions to transform healthcare. As CEO, she provides leadership for research, education and advocacy components of eHealth Initiative and Foundation (eHI). Convening senior executives from every group in healthcare to discuss, identify, and share best practices that transform the delivery of healthcare. Focus areas: improving health and wellness through innovative solutions; interoperability; privacy concerns; artificial intelligence; payment models to support innovative care; and tech tools for chronic care. She led development of dozens of national surveys and published groundbreaking reports. As part of her work with the Foundation, she led grants with California Health Care Foundation, Commonwealth Fund, Aetna Foundation and Bristol Meyers Squibb Foundation. Jennifer is co-chair of the Federal HIT Policy Committee’s Strategy and Innovation Workgroup; member of the HL7 Board of Directors; and a member of the Diabetes Collaborative Stakeholder Panel. Jennifer is a faculty member for the MHA and MHIA graduate programs at George Washington University. Prior to joining eHI, Jennifer headed up the strategic marketing at OpenNetworks, Inc., focusing on security solutions for the healthcare industry. She led healthcare industry relations at MicroStrategy, Inc., focusing on data-mining solutions for the pharmaceutical and healthcare industry. She spent four years at the National Committee for Quality Assurance as Director of Policy and Product Development, helping develop national quality standards for healthcare organizations. Jennifer began her career at the George Washington University Hospital, Medical Center and Health Plan working on quality management initiatives, clinical pathways and healthcare administration. Jennifer earned a master's in Human Resource Development, completed coursework in health administration doctoral program at GWU, and resides in Maryland with her husband and two children.

 

 

This webinar is supported by

eHI Annual Meeting

January 29, 2021

eHI hosted its Annual Meeting from January 26-28th. Five panels discussed lessons learned, industry best practices, and how we move toward a more modern, technology-enabled, and equitable health care system. Panels of experts explored topics related to social determinants of health, health data privacy, policy and advocacy, and modern health care delivery.

For full biographies of panelists, click here.

Links to all videos below. 

eHI CEO Jen Covich Bordenick Interviews Senator Catherine Cortez Masto (D-NV)

eHI was thrilled to host Senator Catherine Cortez Masto (D-NV) for a conversation on healthcare, data privacy, and the importance of federal policy to ensure transparency to the consumer.

Panel #1: TGI2021: Where Are We Heading This Year: 

eHI CEO Jen Covich Bordenick was joined by outgoing Board Chair Dr. Susan Turney, President & CEO of Marshfield Clinic Health System, and incoming Board Chair Amy McDonough, Senior Vice President & General Manager of Fitbit Health Solutions. They discussed expectations for 2021, as well as wearable technology and a discussion on equality in healthcare providers.

"While attitudes have thankfully changed dramatically, we have not arrived at a fully equitable society."

- Dr. Susan Turney

Panel #2: Prioritizing Equality in COVID-19 Vaccine Distribution

eHI's Director of Strategy and Programs Wanneh Dixon joined Damika Barr, JD from Verily Life SciencesAnna Basevich from ArcadiaJ. Michael McGinnis, MD, MA, MPP from the National Academy of Medicine, and Diana Zuskov from LexisNexis Risk Solutions for a discussion on how to engage underserved communities in COVID-19 vaccine distribution and using data-driven approaches to close gaps in health equity.

"I think the biggest takeaway is that there is a lot of data out there and I think we're getting to the point where everyone is convinced data is important, but making it actionable and connecting it down to one individual that you can look at an entire data story for."

- Diana Zuskov

Panel #3: Virtual Care Delivery During COVID-19 and Beyond

eHI CEO Jen Covich Bordenick joined experts Saurabha Bhatnagar, MD of United Healthcare, Adam Pellegrini of CVS Health, and Roy Schoenberg, MD of Amwell. Panelists discussed how their organizations have scaled virtual care delivery during COVID-19 and how they envision the future of health care post-COVID-19.

"For the next generation of telehealth that we want to be known for it has to be built differently to allow for innovation of others to collaborate inside the telehealth encounters or surrounding the telehealth encounters."

- Dr. Roy Schoenberg 

Panel #4: Protecting “Health-ish” Data: Balancing Innovation and Health Data Privacy

eHI's Vice President and Senior Counsel Alice Leiter joined Jodi Daniel, Partner at Crowell & Moring; Laura Hoffman, Assistant Direction of Federal Affairs at the AMA; and Liz Salmi, Senior Strategist, Research Communication at OpenNotes and Senior Multimedia Communications Director at Beth Israel Deaconess Medical Center. Panelists talked about the challenging balance of shoring up legal protections for the increasing amounts of non-HIPAA-covered health data, establishing consumer trust in new technologies, and encouraging innovation in health care and health tech.

"[With respect to the digital Covid contact tracing apps]... There was a great idea, a great need to try to supplement traditional contact tracing for public health purposes with the outbreak of Covid with digital apps and smartphone apps that could use different types of functionality on your phone ...to alert folks when they were exposed to Covid. Unfortunately, we saw with a lot of the early rollouts of those apps that people didn't trust what would happen to the information they provided."

- Laura Hoffman

Upcoming Webinar: Release of the Final Consumer Privacy Framework for Health Data. We are delighted to release our final proposal to shore up protections for non-HIPAA-covered health information and share our plans for phase 2 of our work. Please join us and our colleagues from the Center for Democracy and Technology on February 9 at 2:00. 

Panel #5: Digital Health Policy: Have We Reached a Turning Point?

The last panel of the Annual Meeting was moderated by eHI’s Assistant Vice President of Policy, Catherine Pugh. Catherine was joined by Aashima Gupta, Director, Global Healthcare Strategy and Solutions at Google Cloud; Matthew Roman, Chief Digital Strategy Officer at Duke University Health System; and Dr. Mona Siddiqui, Senior Vice President, Clinical Strategy & Quality at Humana for a discussion on the impact of COVID-19 on health policy, lessons learned, and how we move forward to build a more effective, efficient, and equitable health care system​. 

“I think digital should have a level playing field and I think there’s often been just a much higher bar to get some things approved than in-person care, so my hope is that people begin to see last year as a proof point of what’s possible and continue to enable greater access to care for people through technology and through digital solutions.”

- Dr. Mona Siddiqui

 

WEBINAR: New Strategies for Patient Engagement: Lessons Learned During the Pandemic

January 21, 2021

Are your patients and members so concerned about contracting COVID-19 that they are afraid to seek preventative care? Between deferred care, COVID-19 vaccine engagement, and the need to illuminate and address socioeconomic challenges and health equity, patient engagement presents new challenges as move into 2021. Do your current strategies measure up?

Please join us Lurie Children’s Pediatric Partners, an integrated network in Chicago, and Community Health Plan of Washington, a nonprofit health plan supporting Medicaid and Medicare populations, as they share their experiences and lessons learned from 2020, and discuss challenges ahead.

Both organizations knew early in the spring of 2020 that this year would make patient engagement difficult. They took this opportunity to rethink how they engaged with their populations by taking the lead in educating patients about the new public health threat, offering resources, and sharing guidance on preventative care.

The webinar will look at:

  • Tools to support patients as the pandemic continues
  • Engaging and educating patients around COVID-19 vaccinations
  • Closing preventative care gaps and addressing deferred care
  • Advancing health equity by addressing SDOH at the point of care

 

REGISTRATION NOTE: This webinar will be recorded and made available to registrants should the timing with Inauguration Day pose a conflict.

Speakers:


Anna Basevich
VP, Customer Success
Arcadia

Anna leads customer success at Arcadia, working with customers to build out tailored population health strategies that leverage Arcadia’s analytics and workflow tools.  She oversees the execution of Arcadia’s strategic partnership programs, which expand the transformative impact of the Arcadia Analytics platform.  Anna recently led the expansion of Arcadia’s customer training program to enable healthcare organizations to accelerate their value-based care outcomes.

Anna has worked with Arcadia customers – including health plans, ACOs, independent physician groups, IDNs, and life sciences organizations – across the country to develop and execute strategies to succeed in value-based care. She has deep experience supporting healthcare leaders as they implement effective enterprise-level programs to improve quality, manage cost and utilization, and drive accurate risk-adjusted payments.   She leads and mentors Arcadia teams to help provider networks and health plan customers roll out Arcadia’s tools in an effective and targeted manner to end users and drive platform adoption and change management.

Anna has managed implementations and client services work at Arcadia and at Deloitte Consulting; her past work has included numerous programs around health system quality measurement and improvement under ACO and risk-based contracts, initiatives aimed at improving accuracy and completeness of documentation for risk adjustment, state health insurance exchange implementations, Patient Centered Medical Home transformations, Health Information Exchange strategy and analytics, and large-scale health IT implementations.

Anna received her Bachelor’s degree from Wellesley College.

 


Mackenzie M. Bisset, MSPH, MS, MBA
Director of Operations

Lurie Children’s Pediatric Partners

Mackenzie Bisset, MSPH, MS, MBA is currently the Director of Operations at Lurie Children’s Pediatric Partners where she oversees and manages the Clinically Integrated Network. She helps define the strategy of the CIN, and sets annuals goals; she hires and manages staff; manages vendor partnerships and subcontracts; implemented software to aggregate clinical data and maintain data feeds across the CIN; leads all marketing and communication efforts; and developed the CIN Quality and Safety Plan. She also helped negotiate and oversee the implementation of two Medicaid and three commercial VBCs totaling 140,000 lives and roughly $300 million in medical spend and has successfully achieved savings under these value-based arrangements.

Prior to directing the CIN, Ms. Bisset was the Clinical Quality Consultant for the Care Coordination Entity (CCE) at Lurie Children’s. As part of this role, she also identified opportunities for co-management between specialists and pediatricians; developed learning collaboratives to reduce costs; and improved the appropriateness of referrals while improving outcomes.  Another component of her role was developing clinical care guidelines and quality and utilization metrics to ensure compliance with state requirements as well as identifying opportunities for performance improvement.

Additional previous titles include Accreditation Compliance/Health Services Accreditation Surveyor for the National Commission on Correctional Health care where she evaluated the health care services provided in jails and prisons across the United States. As a Consultant for Hubbert Systems Consulting, she provided subject matter advice on the structures and processes of health care delivery to clients, designed and implemented Quality Improvement and Patient Safety programs and more.


Jen Covich Bordenick
CEO
eHealth Initiative and Foundation

For over 20 years, Jennifer has focused on quality and innovative technology solutions to transform healthcare. As CEO, she provides leadership for research, education and advocacy components of eHealth Initiative and Foundation (eHI). Convening senior executives from every group in healthcare to discuss, identify, and share best practices that transform the delivery of healthcare. Focus areas: improving health and wellness through innovative solutions; interoperability; privacy concerns; artificial intelligence; payment models to support innovative care; and tech tools for chronic care. She led development of dozens of national surveys and published groundbreaking reports. As part of her work with the Foundation, she led grants with California Health Care Foundation, Commonwealth Fund, Aetna Foundation and Bristol Meyers Squibb Foundation. Jennifer is co-chair of the Federal HIT Policy Committee’s Strategy and Innovation Workgroup; member of the HL7 Board of Directors; and a member of the Diabetes Collaborative Stakeholder Panel. Jennifer is a faculty member for the MHA and MHIA graduate programs at George Washington University. Prior to joining eHI, Jennifer headed up the strategic marketing at OpenNetworks, Inc., focusing on security solutions for the healthcare industry. She led healthcare industry relations at MicroStrategy, Inc., focusing on data-mining solutions for the pharmaceutical and healthcare industry. She spent four years at the National Committee for Quality Assurance as Director of Policy and Product Development, helping develop national quality standards for healthcare organizations. Jennifer began her career at the George Washington University Hospital, Medical Center and Health Plan working on quality management initiatives, clinical pathways and healthcare administration. Jennifer earned a master's in Human Resource Development, completed coursework in health administration doctoral program at GWU, and resides in Maryland with her husband and two children.


Jennifer Polello, MHPA, PCMH CCE, MCHES
Senior Director of Quality and Population Health
Community Health Plan of Washington

Jennifer has over 20 years of extensive experience across the healthcare continuum in the areas of public health, chronic disease management, quality improvement, health policy, population health management and clinical informatics.  She has exercised this experience from several points of view across the health care environment and has demonstrated expert facilitation skills in leading teams of clinicians, nurses and physicians through the transformation process of patient care in the ambulatory setting.  Jennifer has worked on regional health information exchange projects and assisted in the design of a clinical decision support tool for patients with type 2 diabetes. She has also served as an Adjunct Clinical Assistant Professor mentoring PharmD candidates at Washington State University.   Jennifer is currently leveraging her knowledge and expertise as the Senior Director of Quality and Population Health at Community Health Plan of Washington where she leads the company’s quality improvement strategies, population health and clinical data integration programs across the Network of 20 community health centers that operate more than 130 clinics across the state. 

 

 

Support for this webinar brought to you by:

WEBINAR: SDOH Impact on Equity and Diversity in Clinical Trials

January 12, 2021

The FDA reports that only five percent of clinical trial participants are Black, fewer than two percent are Asian, and fewer than one percent are Latino. This grossly uneven representation in clinical research means that current treatments may not be equally safe and effective for all populations. These findings suggest a need for a larger focus on the social determinants of health (SDOH) when designing clinical trials. Especially in light of recent concerns over the lack of racial diversity in COVID-19 research, it is urgent that we address this health equity issue.

On Jan 12, eHI will convene leading pharma manufacturers and leaders in public health to discuss current steps being taken to enhance diversity in clinical trials and to address the use of SDOH in the design of clinical trials.  

Areas of discussion will include:

•            Research from studies that reveals how SDOH may have an impact on clinical trials

•            The implications of clinical trials without diversity, equity, or inclusion

•            Current pharma-led initiatives around health equity and diversity in clinical trials

•            Methods for ensuring SDOH is considered during vaccine development for infectious diseases, including COVID-19.

 

Speakers:
 


Jen Covich Bordenick 
CEO
eHealth Initiative and Foundation

 

For over 20 years, Jennifer has focused on quality and innovative technology solutions to transform healthcare. As CEO, she provides leadership for research, education and advocacy components of eHealth Initiative and Foundation (eHI). Convening senior executives from every group in healthcare to discuss, identify, and share best practices that transform the delivery of healthcare. Focus areas: improving health and wellness through innovative solutions; interoperability; privacy concerns; artificial intelligence; payment models to support innovative care; and tech tools for chronic care. She led development of dozens of national surveys and published groundbreaking reports. As part of her work with the Foundation, she led grants with California Health Care Foundation, Commonwealth Fund, Aetna Foundation and Bristol Meyers Squibb Foundation. Jennifer is co-chair of the Federal HIT Policy Committee’s Strategy and Innovation Workgroup; member of the HL7 Board of Directors; and a member of the Diabetes Collaborative Stakeholder Panel. Jennifer is a faculty member for the MHA and MHIA graduate programs at George Washington University. Prior to joining eHI, Jennifer headed up the strategic marketing at OpenNetworks, Inc., focusing on security solutions for the healthcare industry. She led healthcare industry relations at MicroStrategy, Inc., focusing on data-mining solutions for the pharmaceutical and healthcare industry. She spent four years at the National Committee for Quality Assurance as Director of Policy and Product Development, helping develop national quality standards for healthcare organizations. Jennifer began her career at the George Washington University Hospital, Medical Center and Health Plan working on quality management initiatives, clinical pathways and healthcare administration. Jennifer earned a master's in Human Resource Development, completed coursework in health administration doctoral program at GWU, and resides in Maryland with her husband and two children.

 


Luther T Clark, MD, FACC, FACP
Deputy Chief Patient Officer & Global Director, Scientific, Medical and Patient Perspective, Office of the Chief Patient Officer
Merck 

Dr Clark leads Merck’s Patient Insights Team, is co-leader of the team that champions Health Care Equities (including promotion of health literacy and research diversity) and chairs the Patient Engagement, Health Literacy & Clinical Trials Diversity Investigator Initiated Studies Research Committee.  

Prior to joining Merck, Dr Clark was Chief of the Division of Cardiovascular Medicine at the State University of New York Downstate Medical Center (SUNY Downstate) and founding Director of the National Institutes of Health (NIH) funded Brooklyn Health Disparities Research Center.

Dr Clark earned his Bachelor of Arts degree from Harvard College and his Medical degree from Harvard Medical School.  He is a Fellow of the American College of Cardiology (FACC) and the American College of Physicians (FACP), and a past member of the Board of Directors of the Founders Affiliate of the American Heart Association.  He is a nationally and internationally recognized leader in cardiovascular education, clinical investigation, cardiovascular disease prevention, and health equity. He has authored more than 100 publications and edited and was principal contributor to the textbook Cardiovascular Disease and Diabetes (McGraw-Hill).

Dr Clark has received numerous awards and honors, including the Harvard University Alumni Lifetime Achievement Award for Excellence in Medicine.  He is the current President of the Health Science Center at Brooklyn Foundation (HSCB Foundation), SUNY Downstate Medical Center.


Dana Dornsife
Founder and CEO
Lazarex Cancer Foundation

Dana Dornsife founded Lazarex Cancer Foundation, a nationwide non-profit organization, in 2006 in response to a family experience with cancer. The unique mission of Lazarex is to  improve the outcome of cancer care, giving hope, dignity and life to advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and engagement.

In 2016, Dana expanded the mission at Lazarex to bring sustainable and transformational change to the bench to bedside process of clinical trial enrollment, retention, minority participation and equitable access with IMPACT (IMproving Patient Access to Cancer Clinical Trials). Most recently, Lazarex created collaboration around a public health initiative in Philadelphia, PA – Community IMPACT. This bold initiative is aimed at creating a replicable model to improve cancer health outcomes and associated co-morbidities for the residents of medically underserved and socioeconomically challenged minority neighborhoods throughout major metropolitan cities and beyond.

Dana is a graduate of Drexel University in Philadelphia. She is a board member of the USC Brain and Creativity Institute at University of Southern California, serves on the UCSF Cancer Leadership Council, and the MGH Presidents Council. She is on the governing board of the Yosemite Conservancy, in addition to being a council member.  Dana and her husband, Dave Dornsife, a USC Trustee, support a WASH initiative – Water, Sanitation and Hygiene, in 24 African countries through World Vision, an international humanitarian agency.

 


Lorena Kuri
Diversity Strategy  | Global Clinical Trial Planning & Alliances
Bristol Myers-Scribb 

 

Born and raised in Mexico, Lorena is a people oriented, active and sensitive change agent, currently leading BMS’s R&D efforts on Diversity in Clinical Trials. Her experience and transferable skills helped her change careers after more than 14 years in Commercial roles, finding a match in Clinical Operations, expanding the opportunity to help medically underserved populations. Lorena’s business acumen and customer focus have been key to demonstrate results, but more importantly to engage with key stakeholders. She holds a BA in International Business and Masters in Strategic Management and Human Capital. She believes in the value of connecting others and is proud of cultivating networks, helping whenever is needed.

She is an inclusion advocate and stands for what is right.

As a Latina, Immigrant and a Working Mom, Lorena found a way to connect her purpose and power, and is trying to make it right leveraging her intersectionality and the roles she holds at organizations like WOCIP (Women of Color in Pharma), the RedShoeMovement and her hometown Diversity Committee in New Providence NJ, where she lives with her husband and two kids.

 


Lili Gil Valletta
Co-Founder and CEO
CIEN+ and CulturIntel

Lili is an award-winning entrepreneur, recognized cultural intelligence® expert, A.I. tech innovator and World Economic Forum Young Global Leader. After a successful corporate career, including a 10-year tenure at Johnson & Johnson, Lili co-founded CIEN+ and CulturIntel. Her firm is globally recognized as a leader in AI-powered market research, business consulting and marketing strategies to accelerate and drive innovation and profits; with an expertise in the health and wellness sector. Culturintel’s ability to mine open-source digital discussions in real-time to map patient journeys and health insights by segments-globally, have been published by Harvard Medical School, featured at the 2019 World Psychiatry Summit and presented in Davos 2020, among others.

Some of her clients include Merck, Abbott, Boehringer Ingelheim, Johnson & Johnson, Novartis, CVS/Aetna, WW (Weightwatchers) among other Fortune 500’s. She is a regular TV commentator seen on Fox News, Fox Business and CNN en Español. Lili is also one of only 2.6% of Latinos serving on a Fortune 500+ public board, as an independent director at Zumiez (NASDAQ: ZUMZ). Other boards she serves on include AUA Private Equity Partners, Harvard Women's Leadership Board, National Board of Directors of the YMCA USA and the American Heart Association’s Communications & Marketing Coordinating Committee. In 2020, she was selected to join the advisory board for Social Determinants of Health Taskforce at the World Economic Forum. Some of her recent awards include 2019 Top 10 Innovation Catalyst by Medical Media & Marketing (MM&M), 2019 Silicon Valley Visionary, 2018 Top 50 Most Influential in Healthcare by MM&M, 2018 U.S. Hispanic Businessperson of the Year by the U.S. Hispanic Chamber of Commerce, Top 100 Most Powerful Women of NY, among others. She is an active voice elevating promoting equity and business inclusion, collaborating across various initiatives at the United

Nations, The World Economic Forum and The White House. Lili holds a degree in Business Administration from Southwestern Adventist University, an M.B.A. from the University of Colorado and an executive degree from the Harvard Kennedy School in Global Leadership and Public Policy. She lives in New York with her husband and her two sons.

 

 

Support for this webinar brought to you by:

WEBINAR: How Providers are Scaling Virtual Care: Best Practices and Lessons Learned from the Leaders

The pandemic reshaped healthcare’s utilization of virtual care. Almost overnight, providers quickly mobilized telehealth programs, reshaped audio-only check-ins, and revamped patient engagement solutions. As healthcare leaders refine and grow these programs over the coming months, our experts detail the strategies and practices to help organizations scale from pilots to enterprise-wide, comprehensive virtual care deployments.

WEBINAR: New Strategies for Patient Engagement: Lessons Learned During the Pandemic

Are your patients and members so concerned about contracting COVID-19 that they are afraid to seek preventative care? Between deferred care, COVID-19 vaccine engagement, and the need to illuminate and address socioeconomic challenges and health equity, patient engagement presents new challenges as move into 2021. Do your current strategies measure up?

WEBINAR: SDOH Impact on Equity and Diversity in Clinical Trials

The FDA reports that only five percent of clinical trial participants are Black, fewer than two percent are Asian, and fewer than one percent are Latino. This grossly uneven representation in clinical research means that current treatments may not be equally safe and effective for all populations. These findings suggest a need for a larger focus on the social determinants of health (SDOH) when designing clinical trials. Especially in light of recent concerns over the lack of racial diversity in COVID-19 research, it is urgent that we address this health equity issue.